Pelthos Therapeutics Inc. Deal History & Licensing Activity
Pelthos Therapeutics Inc. is a biotech headquartered in US. Over the past three years, Pelthos Therapeutics Inc. has been involved in 3 licensing and acquisition transactions, with a primary focus on Small Molecules (5 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Small Molecules
Focus Area
Dermatology
Pelthos Therapeutics Inc. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Pelthos Therapeutics Inc. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Xeglyze | Hatchtech Pty Ltd | Small Molecules | Approved | acquisition | Dec 1, 2025 |
| Xepi (ozenoxacin) Cream, 1% | Pelthos Therapeutics, Inc. | Small Molecules | Approved | acquisition | Nov 7, 2025 |
Pelthos Therapeutics Inc. Pipeline Focus
Therapeutic areas and modalities where Pelthos Therapeutics Inc. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Pelthos Therapeutics Inc. Strategic Signals
Key indicators of Pelthos Therapeutics Inc.'s licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Pelthos Therapeutics Inc.'s Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Pelthos Therapeutics Inc. Licensing & Deal Activity
Pelthos Therapeutics Inc. is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 3 deals over the past three years, Pelthos Therapeutics Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Pelthos Therapeutics Inc. include Dermatology (5 deals and trials). In terms of modality, Pelthos Therapeutics Inc. has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Pelthos Therapeutics Inc. and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Pelthos Therapeutics Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.